Statistics about Health, Pharma & Medtech in United States
Statistics
- Aptinyx net cash 2018-2022
- Aptevo Therapeutics total equity 2019-2023
- Aptevo Therapeutics liabilities 2019-2023
- Aptevo Therapeutics operating profit 2019-2023
- Dermtech, Inc. net income 2019-2023
- Nkarta liabilities 2019-2023
- Aptevo Therapeutics net cash 2019-2023
- Nurix Therapeutics liabilities 2019-2023
- Bio-Path Holdings net cash 2019-2023
- Dmk Pharmaceuticals total equity 2018-2022
- Ocugen revenue 2019-2023
- Aprea Therapeutics total assets 2019-2023
- Relay Therapeutics operating profit 2019-2023
- Odonate Therapeutics, Inc. net income 2017-2019
- Ocugen net income 2018-2022
- Design Therapeutics liabilities 2020-2023
- Design Therapeutics total equity 2019-2023
- Dmk Pharmaceuticals net income 2018-2019
- Design Therapeutics net cash 2020-2023
- Dmk Pharmaceuticals revenue 2018-2022
- Dmk Pharmaceuticals gross profit 2018-2022
- Design Therapeutics operating profit 2020-2023
- Aprea Therapeutics liabilities 2018-2022
- Design Therapeutics total assets 2020-2023
- Design Therapeutics net income 2020-2023
- Regulus Therapeutics operating profit 2019-2023
- Aprea Therapeutics total equity 2019-2023
- Regen Biopharma operating profit 2019-2023
- Dmk Pharmaceuticals liabilities 2018-2022
- Bio-Path Holdings total equity 2019-2023
- Onconetix, Inc. total assets 2021-2023
- Dmk Pharmaceuticals total assets 2018-2022
- Nkarta operating profit 2019-2023
- Bio-Path Holdings total assets 2019-2023
- Onconetix, Inc. total equity 2020-2023
- Onconetix, Inc. liabilities 2021-2023
- Aprea Therapeutics net cash 2019-2023
- Dermtech, Inc. total equity 2019-2023
- Dmk Pharmaceuticals net cash 2018-2022
- Aptinyx net income 2018-2022
- Aptinyx operating profit 2018-2022
- Atreca, Inc. net cash 2018-2022
- Atreca, Inc. net income 2018-2022
- Dyne Therapeutics total assets 2019-2023
- Nuvation Bio total equity 2019-2023
- Regenerx Biopharmaceuticals Inc total equity 2018-2022
- Rigel Pharmaceuticals total equity 2019-2023
- Ocular Therapeutix total assets 2019-2023
- Opko Health gross profit 2009-2012
- Relmada Therapeutics, Inc. total equity 2019-2023
- Rallybio total equity 2019-2023
- Recursion Pharmaceuticals total assets 2020-2023
- Astria Therapeutics, Inc. net cash 2019-2023
- Nuvalent total equity 2019-2023
- Astria Therapeutics, Inc. liabilities 2019-2023
- Astria Therapeutics, Inc. operating profit 2019-2023
- Atara Biotherapeutics total equity 2019-2023
- Astria Therapeutics, Inc. net income 2019-2023
- Rockwell Medical total equity 2019-2023
- Nuvectis Pharma total assets 2021-2023
- Arcus Biosciences net income 2019-2023
- Arcus Biosciences revenue 2019-2023
- Reviva Pharmaceuticals Holdings, Inc. total assets 2019-2023
- Arcus Biosciences operating profit 2019-2023
- Nuvectis Pharma total equity 2020-2023
- Arcus Biosciences liabilities 2017-2021
- Artiva Biotherapeutics, Inc. total equity 2022-2023
- Atara Biotherapeutics liabilities 2019-2023
- Arcus Biosciences total equity 2019-2023
- Arcus Biosciences net cash 2019-2023
- Arcus Biosciences total assets 2019-2023
- Atlantic Coastal Acquisition operating profit 2022-2023
- Atlantic Coastal Acquisition liabilities 2021-2023
- Atlantic Coastal Acquisition net cash 2022-2023
- Repligen total equity 2019-2023
- Rhythm Pharmaceuticals total assets 2019-2023
- Atara Biotherapeutics operating profit 2019-2023
- Aura Biosciences total assets 2020-2023
- Rigel Pharmaceuticals total assets 2019-2023
- Avalon Globocare Corp. liabilities 2019-2023
- Avalon Globocare Corp. revenue 2019-2023
- Rhythm Pharmaceuticals total equity 2019-2023
- Avalon Globocare Corp. net income 2019-2023
- Aura Biosciences total equity 2019-2023
- Nuvectis Pharma net cash 2021-2023
- Relmada Therapeutics, Inc. total assets 2019-2023
- Rallybio total assets 2020-2023
- Aspira Women'S Health Inc. gross profit 2019-2023
- Aspira Women'S Health Inc. operating profit 2019-2023
- Rockwell Medical total assets 2019-2023
- Aspira Women'S Health Inc. revenue 2019-2023
- Aura Biosciences net cash 2020-2023
- Astria Therapeutics, Inc. total equity 2019-2023
- Aspira Women'S Health Inc. liabilities 2019-2023
- Aspira Women'S Health Inc. net cash 2019-2023
- Aspira Women'S Health Inc. total equity 2019-2023
- Aspira Women'S Health Inc. total assets 2019-2023
- Ocular Therapeutix net cash 2019-2023
- Nuvation Bio total assets 2020-2023
- Nuvalent total assets 2020-2023